| Catalog Number | 80002-1-RR |
| Synonyms | TDP-43 (for IF/FC), TARDBP, TDP 43, TDP43, TDP-43 |
| Host | Rabbit |
| Reactivity | human, mouse, rat |
| Form | Liquid |
| Formulation | PBS, Azide, Glycerol |
| Applications | WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA, ChIP-qPCR |
| Host / Isotype | Rabbit / IgG |
| Tested Applications — Positive WB detected in | HeLa cells, HAP1 cells, K-562 cells, Neuro-2a cells, C6 cells |
| Tested Applications — Positive IP detected in | HAP1 cells, HeLa cells |
| Tested Applications — Positive IHC-Autostainer detected in | human brain tissue |
| Tested Applications — Positive IHC detected in | mouse brain tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Tested Applications — Positive IF-P detected in | rat brain tissue |
| Tested Applications — Positive IF/ICC detected in | HeLa cells, HepG2 cells, SH-SY5Y cells, HAP1 cells |
| Tested Applications — Positive FC (Intra) detected in | HeLa cells |
| Tested Applications — Positive ChIP-qPCR detected in | HEK-293T cells |
| Recommended Dilutions — Western Blot (WB) | WB : 1:20000-1:100000 |
| Recommended Dilutions — Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Recommended Dilutions — Immunohistochemistry (IHC) | IHC : 1:1600-1:6400 |
| Recommended Dilutions — Immunofluorescence (IF)-P | IF-P : 1:800-1:3200 |
| Recommended Dilutions — Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| Recommended Dilutions — Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| Positive WB detected in | HeLa cells, HAP1 cells, K-562 cells, Neuro-2a cells, C6 cells |
| Positive IP detected in | HAP1 cells, HeLa cells |
| Positive IHC-Autostainer detected in | human brain tissue |
| Positive IHC detected in | mouse brain tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | rat brain tissue |
| Positive IF/ICC detected in | HeLa cells, HepG2 cells, SH-SY5Y cells, HAP1 cells |
| Positive FC (Intra) detected in | HeLa cells |
| Positive ChIP-qPCR detected in | HEK-293T cells |
| Western Blot (WB) | WB : 1:20000-1:100000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC)-AUTOSTAINER | IHC-AUTOSTAINER : 1:50-1:500 |
| Immunohistochemistry (IHC) | IHC : 1:1600-1:6400 |
| Immunofluorescence (IF)-P | IF-P : 1:800-1:3200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| CHIP-QPCR | CHIP-QPCR : 1:10-1:100 |
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Class | Recombinant |
| Type | Antibody |
| Immunogen | CatNo: Ag1231 Product name: Recombinant human TDP-43 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-260 aa of BC001487 Sequence: MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNA Predict reactive species |
| Full Name | TAR DNA binding protein |
| Calculated Molecular Weight | 43 kDa |
| Observed Molecular Weight | 43 kDa |
| GenBank Accession Number | BC001487 |
| Gene Symbol | TDP-43 |
| Gene ID (NCBI) | 23435 |
| RRID | AB_2882934 |
| Conjugate | Unconjugated |
| Purification Method | Protein A purification |
| UNIPROT ID | Q13148 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA. |
| FC protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Download protocol |
| IF protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Download protocol |
| IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Download protocol |
| IP protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Download protocol |
| WB protocol for TDP-43 (N-terminal) antibody 80002-1-RR | Download protocol |
| human | WB,IF Mol Biol Cell Patient-derived induced pluripotent stem cells with a C9orf72 expansion as a model to study frontotemporal dementia pathologies. Authors - Sonia Infante-Tadeo View Article |
| mouse | WB,IF Neural Regen Res 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis Authors - Shi-Shi Jiang View Article |
| Citations | 9 |
| Dilutions | WB : 1:20000-1:100000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC-AUTOSTAINER : 1:50-1:500 IHC : 1:1600-1:6400 IF-P : 1:800-1:3200 IF/ICC : 1:200-1:800 FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension CHIP-QPCR : 1:10-1:100 |
| Isotype | IgG |
| Clonality | Recombinant |
| Clone Number | 16A22 |
| Conjugation | Unconjugated |
The TARDBP gene encodes the TDP-43 protein, initially found to repress HIV-1 transcription by binding TAR DNA. TDP-43 has since been shown to bind RNA as well as DNA, and have multiple functions in transcriptional repression, translational regulation and pre-mRNA splicing. For instance, it is reported to regulate alternate splicing of the CTFR gene. In 2006 Neumann et al. found that hyperphosphorylated, ubiquitinated and/or cleaved forms of TDP-43, collectively known as pathological TDP-43, play a major role in the disease mechanisms of ubiquitin-positive, tau- and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in amyotrophic lateral sclerosis (ALS). Proteintech's 80002-1-RR is a rabbit recombinant TDP-43 antibody recognizing N-terminal TDP-43. It recognizes the intact 43 kDa protein as well as all posttranslationally modified and truncated forms in multiple applications. Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659, 19823856, 21666678, 22193176) Recently TDP-43 has been reported to be overexpressed in triple negative breast cancer (TNBC) and it may be a potential target for TNBC diagnosis and drug design. (PMID: 29581274) 80002-1-RR antibody works well in IF experiment. Protocols Product Specific Protocols FC protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IF protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IP protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol WB protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols
Publications